Cedric Pobel
6PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 03, 2025
Dabogratinib (TYRA-300), an FGFR3 Isoform-Selective Inhibitor: Preclinical and Initial Clinical Evidence of Antitumor Activity.Jacqueline H Starrett, Eric L Allen, Melissa Neal
|Oct 14, 2025
Dabogratinib (TYRA-300), an FGFR3 Isoform-Selective Inhibitor: Preclinical and Initial Clinical Evidence of Antitumor Activity.Jacqueline H Starrett, Eric L Allen, Melissa Neal
|Jun 28, 2023
Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer.Francesco Facchinetti, Antoine Hollebecque, Floriane Braye
|Jun 26, 2023
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors.Naoual Menssouri, Loïc Poiraudeau, Carole Helissey
|Aug 12, 2021
Cabazitaxel multiple rechallenges in metastatic castration-resistant prostate cancer.Cedric Pobel, Edouard Auclin, Diego Teyssonneau
|Jan 19, 2021
Cabazitaxel schedules in metastatic castration-resistant prostate cancer: a review.Cedric Pobel, Edouard Auclin, Adrien Procureur
Pageof 1
Frequent Collaborators
4 joint publications
Yohann Loriot
2 joint publications
Jacqueline H Starrett
2 joint publications
Carole Helissey
2 joint publications
Benjamin Besse
2 joint publications
Erik Goluboff
2 joint publications
Ludovic Bigot
2 joint publications
Stefan Michiels
2 joint publications
Luc Friboulet
2 joint publications
Jean-Yves Scoazec
2 joint publications
Santiago Ponce-Aix
